Table 2.
Competitive binding of SARS-CoV-2 spike protein S1, anticoagulation factors AT and HCII to heparin on microarrays.
| Competitive binding experiments | Residual bindinga |
Residual bindingb |
||
|---|---|---|---|---|
| AT | S1 | HCII | S1 | |
| i) with premixed S1 & AT/HCII | 96.4% ± 23.1% | 62.0% ± 12.5% | 73.3% ± 15.6% | 25.8% ± 0.5% |
| ii) with AT/HCII followed by S1 | 104.8% ± 18.7% | 24.3% ± 1.7% | 76.9% ± 13.0% | 11.4% ± 2.0% |
| iii) with S1 followed by AT/HCII | 76.3% ± 21.0% | 67.0% ± 27.8% | 78.5% ± 11.4% | 92.7% ± 18.0% |
Means and standard deviations were obtained from 8 replicate points and three parallel experiments. The ratio of the mean value of the competition experiment to that of the control experiment was calculated shown as percentage to indicate the degree of S protein competition.
Concentrations used: S1 (2 μg/mL) and AT (1 μg/mL).
Concentration used: S1 (4 μg/mL) and HCII (2 μg/mL).